Login
Navigate Fool.com
Will LXRX beat
the market?
Community Rating: 2 Stars: Unattractive

2.19 0.00 (0.00%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $2.17
Previous Close $2.19
Daily Range $2.13 - $2.19
52-Week Range $1.52 - $3.28
Market Cap $1.1B
P/E Ratio -9.95
Dividend (Yield) $0.00 (0.0%)
Volume 784,943
Average Daily Volume 938,333
Current FY EPS -$0.17

How do you think LXRX
will perform against the market?

Top LXRX Bull/Bear Pitches

 

sandybdr (< 20)
Submitted August 16, 2011

Biopharma company that works on mouse genetics , localizes potential drug targets , and then attempts to make drugs specific for those targets. Completely speculative play. If LX4211 succeeds (phase I … More

0 Replies Reply Report this Post
 

Brosan (1.25)
Submitted January 28, 2011

With more less than 80c per share available in cash, LXRX will have a very hard time to keep their heads above water. The me-too compound, LX4211, seems to be stuck in the ground due to the lack of in … More

1 Replies Reply Report this Post

News & Commentary

Why Lexicon Is Poised to Pull Back

Market-lagging returns could be written in this 2-Star.

Market Wrap for Monday, April 29: Stocks Start Week With a Rally

3 Stocks With Insider Interest

Keryx Defies Gravity

Keryx defies gravity with its secondary offering.

Why Lexicon Pharmaceuticals Is Poised to Underperform

Market-lagging returns could be written in this 2-Star.

Whoa! What Just Happened to My Stock?

These stocks bounced higher yesterday, but are they about to make a return trip to Earth?

Stocks Surge as Fiscal Cliff Deal Appears Close

How Should Investors Play Vringo In 2013?

Speculators love this stock. Investors, not so much.

Could a Virus Make You Lots of Money?

Can investors reap rewards from Oncolytics Biotech's cancer-killing virus?

Lexicon Pharmaceuticals IBS Drug Gets on FDA Fast Track

LX1033 IBS-d drug currently in phase 2 trials.

See More LXRX News...

Sector

Healthcare

Industry

Drugs

Lexicon Pharmaceuticals, Inc. (LXRX) Description

A biopharmaceutical company focused on the discovery and development of breakthrough treatments for human disease. Website: http://www.lexicon-genetics.com/

Featured Broker Partners

Learn more about our new Fool ticker page!

Take a Tour
no thanks